Claritev Stock News

Claritev Corporation (CTEV) Presents at Bank of America Leveraged Finance Conference Transcript

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”),...

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common sto...

Claritev Corporation ( CTEV ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Todd Friedman - Vice President of Investor Relations Travis Dalton - CEO, President & Chairman Doug Garis - Executive VP & CFO Conference Call Participants Joshua Raskin - Nephron Research LLC Daniel Grosslight - Citigroup Inc. Exchange Research Jessica Tassan - Piper Sandler & Co., Research Di...

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Third Quarter 2025 Results.

MCCLEAN, Va. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated ...

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Third Quarter 2025 Earnings Call.